Table 1.
Neonatal outcomes | F (%)* N = 662 |
---|---|
Gestational age at delivery (weeks) | |
Extremely preterm (<28) | 1 (0.2) |
Very preterm (28–31) | 14 (2.1) |
Late preterm (32–36) | 121 (18.3) |
Term (37–42) | 526 (79.5) |
Birth weight (g) | |
Low (<2500) | 142 (21.5) |
Appropriate (2500–4000) | 512 (77.3) |
Large (>4000) | 5 (0.8) |
Not documented | 3 (0.5) |
Respiratory complications | 53 (8.0) |
Sepsis | 43 (6.5) |
Hypocalcaemia | 34 (5.1) |
Neonatal Jaundice | 66 (10.0) |
Total Bilirubin 1.0–5.0 (mg/dl) | 303 (45.8) |
Total Bilirubin 5.1–10.0 | 199 (30.1) |
Total Bilirubin 10.1–15.0 | 33 (5.0) |
Total Bilirubin 15.1–20.0 | 61 (9.2) |
Total Bilirubin not available | |
Need for phototherapy | 98 (14.8) |
APGAR at 1 min | 7.9 (± 0.6) |
APGAR at 5 min | 8.9 (± 0.4) |
Low APGAR at 5 min (Score < 7) | 3 (0.5) |
NICU admission | |
Less than 24 h | 10 (1.5) |
More than 24 h | 70 (10.6) |
Neonatal TSH (at 48 h) (mIU/L) | 4.1 (2.4–6.8) |
Neonatal death | |
Early (<7days) | 5 (0.8) |
Late (between 7-28) | 5 (0.8) |
*Data are expressed as mean ± standard deviation, median (percentiles 25–75), or frequencies.
APGAR: Appearance, Pulse, Grimace, Activity, and Respiration; NICU: neonatal intensive care admission; TSH: thyroid-stimulating hormone.